494 related articles for article (PubMed ID: 25234947)
1. Hepatic PTEN deficiency improves muscle insulin sensitivity and decreases adiposity in mice.
Peyrou M; Bourgoin L; Poher AL; Altirriba J; Maeder C; Caillon A; Fournier M; Montet X; Rohner-Jeanrenaud F; Foti M
J Hepatol; 2015 Feb; 62(2):421-9. PubMed ID: 25234947
[TBL] [Abstract][Full Text] [Related]
2. Hepatic stearoyl CoA desaturase 1 deficiency increases glucose uptake in adipose tissue partially through the PGC-1α-FGF21 axis in mice.
Aljohani A; Khan MI; Bonneville A; Guo C; Jeffery J; O'Neill L; Syed DN; Lewis SA; Burhans M; Mukhtar H; Ntambi JM
J Biol Chem; 2019 Dec; 294(51):19475-19485. PubMed ID: 31690632
[TBL] [Abstract][Full Text] [Related]
3. Sortilin deficiency improves the metabolic phenotype and reduces hepatic steatosis of mice subjected to diet-induced obesity.
Rabinowich L; Fishman S; Hubel E; Thurm T; Park WJ; Pewzner-Jung Y; Saroha A; Erez N; Halpern Z; Futerman AH; Zvibel I
J Hepatol; 2015 Jan; 62(1):175-81. PubMed ID: 25173968
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-1α deficiency reduces adiposity, glucose intolerance and hepatic de-novo lipogenesis in diet-induced obese mice.
Almog T; Kandel Kfir M; Levkovich H; Shlomai G; Barshack I; Stienstra R; Lustig Y; Leikin Frenkel A; Harari A; Bujanover Y; Apte R; Shaish A; Harats D; Kamari Y
BMJ Open Diabetes Res Care; 2019; 7(1):e000650. PubMed ID: 31749969
[TBL] [Abstract][Full Text] [Related]
5. Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake.
Cedó L; Santos D; Roglans N; Julve J; Pallarès V; Rivas-Urbina A; Llorente-Cortes V; Laguna JC; Blanco-Vaca F; Escolà-Gil JC
PLoS One; 2017; 12(12):e0189834. PubMed ID: 29244870
[TBL] [Abstract][Full Text] [Related]
6. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
7. Daidzein supplementation prevents non-alcoholic fatty liver disease through alternation of hepatic gene expression profiles and adipocyte metabolism.
Kim MH; Park JS; Jung JW; Byun KW; Kang KS; Lee YS
Int J Obes (Lond); 2011 Aug; 35(8):1019-30. PubMed ID: 21157426
[TBL] [Abstract][Full Text] [Related]
8. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
[TBL] [Abstract][Full Text] [Related]
9. Adipose tissue inflammation contributes to short-term high-fat diet-induced hepatic insulin resistance.
Wiedemann MS; Wueest S; Item F; Schoenle EJ; Konrad D
Am J Physiol Endocrinol Metab; 2013 Aug; 305(3):E388-95. PubMed ID: 23736545
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor prolyl hydroxylase 1 (PHD1) deficiency promotes hepatic steatosis and liver-specific insulin resistance in mice.
Thomas A; Belaidi E; Aron-Wisnewsky J; van der Zon GC; Levy P; Clement K; Pepin JL; Godin-Ribuot D; Guigas B
Sci Rep; 2016 Apr; 6():24618. PubMed ID: 27094951
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice.
Brachs S; Winkel AF; Tang H; Birkenfeld AL; Brunner B; Jahn-Hofmann K; Margerie D; Ruetten H; Schmoll D; Spranger J
Mol Metab; 2016 Nov; 5(11):1072-1082. PubMed ID: 27818933
[TBL] [Abstract][Full Text] [Related]
12. Liver X receptors regulate de novo lipogenesis in a tissue-specific manner in C57BL/6 female mice.
Korach-André M; Archer A; Gabbi C; Barros RP; Pedrelli M; Steffensen KR; Pettersson AT; Laurencikiene J; Parini P; Gustafsson JÅ
Am J Physiol Endocrinol Metab; 2011 Jul; 301(1):E210-22. PubMed ID: 21521718
[TBL] [Abstract][Full Text] [Related]
13. Reduced hepatic lipid content in Pten-haplodeficient mice because of enhanced AKT2/PKBβ activation in skeletal muscle.
Schultze SM; Dietrich M; Hynx D; Geier A; Niessen M; Spinas GA; Hemmings BA; Tschopp O
Liver Int; 2015 Apr; 35(4):1354-66. PubMed ID: 24845341
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle salt inducible kinase 1 promotes insulin resistance in obesity.
Nixon M; Stewart-Fitzgibbon R; Fu J; Akhmedov D; Rajendran K; Mendoza-Rodriguez MG; Rivera-Molina YA; Gibson M; Berglund ED; Justice NJ; Berdeaux R
Mol Metab; 2016 Jan; 5(1):34-46. PubMed ID: 26844205
[TBL] [Abstract][Full Text] [Related]
15. Deletion of hepatic carbohydrate response element binding protein (ChREBP) impairs glucose homeostasis and hepatic insulin sensitivity in mice.
Jois T; Chen W; Howard V; Harvey R; Youngs K; Thalmann C; Saha P; Chan L; Cowley MA; Sleeman MW
Mol Metab; 2017 Nov; 6(11):1381-1394. PubMed ID: 29107286
[TBL] [Abstract][Full Text] [Related]
16. Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice.
Obata A; Kubota N; Kubota T; Iwamoto M; Sato H; Sakurai Y; Takamoto I; Katsuyama H; Suzuki Y; Fukazawa M; Ikeda S; Iwayama K; Tokuyama K; Ueki K; Kadowaki T
Endocrinology; 2016 Mar; 157(3):1029-42. PubMed ID: 26713783
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
18. CD40 deficiency in mice exacerbates obesity-induced adipose tissue inflammation, hepatic steatosis, and insulin resistance.
Guo CA; Kogan S; Amano SU; Wang M; Dagdeviren S; Friedline RH; Aouadi M; Kim JK; Czech MP
Am J Physiol Endocrinol Metab; 2013 May; 304(9):E951-63. PubMed ID: 23482447
[TBL] [Abstract][Full Text] [Related]
19. Combined effects of rosiglitazone and conjugated linoleic acid on adiposity, insulin sensitivity, and hepatic steatosis in high-fat-fed mice.
Liu LF; Purushotham A; Wendel AA; Belury MA
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1671-82. PubMed ID: 17322064
[TBL] [Abstract][Full Text] [Related]
20. Abrogation of hepatic ATP-citrate lyase protects against fatty liver and ameliorates hyperglycemia in leptin receptor-deficient mice.
Wang Q; Jiang L; Wang J; Li S; Yu Y; You J; Zeng R; Gao X; Rui L; Li W; Liu Y
Hepatology; 2009 Apr; 49(4):1166-75. PubMed ID: 19177596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
